Latest News and Press Releases

TORONTO, June 17, 2019 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “company”) is pleased to report financial results for the first quarter of fiscal 2020, the period...

TORONTO, May 01, 2019 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC/Pink:POLXF) (the “Company”) reports financial results for its fiscal year ended January 31, 2019. All figures are...

TORONTO, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC/Pink:POLXF) announces 3rd quarter financial results. Financial results for the third quarter of fiscal 2019,...

TORONTO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC MKTS:POLXF) (the “Company”) operating as Dextran Products, today announced it has received two awards for water...

TORONTO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC/Pink:POLXF) (the “Company”) today announced financial results for the second quarter of the 2019 fiscal year. The...

TORONTO, June 15, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) reports financial results for the first quarter of fiscal 2019, the period ending April...

TORONTO, May 01, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC/Pink:POLXF) (the “Company”) reports financial results for its fiscal year ended January 31, 2018. All figures are...

TORONTO, May 01, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC Pink:POLXF) (the “Company”) reports financial results for its fiscal year ended January 31, 2018. All figures are...

TORONTO, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC Pink:POLXF) is pleased to provide 3rd quarter financial results. Overcoming sales and production challenges, the Order...

TORONTO, Sept. 15, 2017 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC MKTS:POLXF) (the “Company”) today announced financial results for the second quarter of the 2018 fiscal year. The...